PubRank

Tomoaki Kato

Author PubWeight™ 67.64‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Standing the test of time: outcomes of a decade of prioritizing patients with hepatocellular carcinoma, results of the UNOS natural geographic experiment. Hepatology 2014 3.29
2 Distribution and compartmentalization of human circulating and tissue-resident memory T cell subsets. Immunity 2012 3.21
3 Mucosal vascular alterations in isolated small-bowel allografts: relationship to humoral sensitization. Am J Transplant 2003 1.64
4 Intestinal transplantation for the treatment of neoplastic disease. J Surg Oncol 2005 1.62
5 Transplantation of the abdominal wall. Lancet 2003 1.51
6 Infrahepatic vena cavocavostomy, a modification of the piggyback technique for liver transplantation. Am Surg 2009 1.40
7 Analysis of vascular access in intestinal transplant recipients using the Miami classification from the VIIIth International Small Bowel Transplant Symposium. Transplantation 2005 1.40
8 Living-related intestinal transplantation for a patient with hypoganglionosis. Pediatr Transplant 2006 1.39
9 100 multivisceral transplants at a single center. Ann Surg 2005 1.34
10 Alemtuzumab (Campath-1H) combined with tacrolimus in intestinal and multivisceral transplantation. Transplantation 2003 1.28
11 Diabetes, body mass index, and outcomes in hepatocellular carcinoma patients undergoing liver transplantation. Transplantation 2012 1.03
12 The role of donor bone marrow infusions in withdrawal of immunosuppression in adult liver allotransplantation. Am J Transplant 2005 1.01
13 Preliminary experience with alemtuzumab (Campath-1H) and low-dose tacrolimus immunosuppression in adult liver transplantation. Transplantation 2004 0.99
14 Ninety-five cases of intestinal transplantation at the University of Miami. J Gastrointest Surg 2002 0.98
15 Effect of protocol Doppler ultrasonography and urgent revascularization on early hepatic artery thrombosis after pediatric liver transplantation. Arch Surg 2002 0.95
16 Piggyback technique in adult orthotopic liver transplantation: an analysis of 1067 liver transplants at a single center. HPB (Oxford) 2006 0.95
17 Arabidopsis ENHANCED DISEASE RESISTANCE 1 is required for pathogen-induced expression of plant defensins in nonhost resistance, and acts through interference of MYC2-mediated repressor function. Plant J 2011 0.95
18 Loss of heterochromatin protein 1 gamma reduces the number of primordial germ cells via impaired cell cycle progression in mice. Biol Reprod 2011 0.94
19 Preliminary experience with campath 1H (C1H) in intestinal and liver transplantation. Transplantation 2003 0.93
20 Current status of transplantation of the small intestine. Transplantation 2007 0.93
21 Living-related liver transplantation with renoportal anastomosis for a patient with large spontaneous splenorenal collateral. Transplantation 2003 0.92
22 Use of older controlled non-heart-beating donors for liver transplantation. Transplantation 2003 0.92
23 Partial abdominal evisceration, ex vivo resection, and intestinal autotransplantation for the treatment of pathologic lesions of the root of the mesentery. J Am Coll Surg 2003 0.92
24 Histopathological changes after microwave coagulation therapy for patients with hepatocellular carcinoma: review of 15 explanted livers. Am J Gastroenterol 2003 0.91
25 Burkitt s lymphoma variant of post-transplant lymphoproliferative disease (PTLD). Pathol Oncol Res 2002 0.91
26 Small-bowel allograft biopsies in the management of small-intestinal and multivisceral transplant recipients: histopathologic review and clinical correlations. Arch Pathol Lab Med 2012 0.91
27 Living-donor liver transplantation with renoportal anastomosis for patients with large spontaneous splenorenal shunts. Transplantation 2005 0.90
28 Characterization of an elicitor-induced rice WRKY gene, OsWRKY71. Biosci Biotechnol Biochem 2008 0.90
29 Intestinal and multivisceral transplantation in children with severe gastrointestinal dysmotility. J Pediatr Surg 2005 0.90
30 Use of liver grafts from donors positive for antihepatitis B-core antibody (anti-HBc) in the era of prophylaxis with hepatitis-B immunoglobulin and lamivudine. Transplantation 2003 0.89
31 Intrahepatic biliary strictures without hepatic artery thrombosis after liver transplantation: an analysis of 1,113 liver transplantations at a single center. Transplantation 2005 0.87
32 Effect of liver transplantation on spleen size, collateral veins, and platelet counts. World J Surg 2010 0.87
33 Concurrent infantile hemangioendothelioma and mesenchymal hamartoma in a developmentally arrested liver of an infant requiring hepatic transplantation. Pediatr Dev Pathol 2004 0.87
34 Lamivudine monoprophylaxis for liver transplant recipients with non-replicating hepatitis B virus infection. Clin Transplant 2007 0.86
35 Differential transcriptome patterns for acute cellular rejection in recipients with recurrent hepatitis C after liver transplantation. Liver Transpl 2009 0.85
36 Exfoliative bowel rejection--a dangerous loss of integrity. Pediatr Transplant 2004 0.84
37 Portal versus systemic drainage of small bowel allografts: comparative assessment of survival, function, rejection, and bacterial translocation. J Am Coll Surg 2002 0.83
38 Subclinical rejection in the initial postoperative period in small intestinal transplantation: a negative influence on graft survival. Transplantation 2007 0.83
39 Adenovirus infection in pediatric liver and intestinal transplant recipients: utility of DNA detection by PCR. Am J Transplant 2003 0.83
40 Prevention of catheter-related bacteremia in pediatric intestinal transplantation/short gut syndrome children with long-term central venous catheters. Pediatr Transplant 2007 0.83
41 Serum adiponectin is associated with worsened overall survival in a prospective cohort of hepatocellular carcinoma patients. Oncology 2014 0.83
42 Intestinal and multivisceral transplantation after abdominal trauma. J Trauma 2004 0.83
43 Comparison of hepatic resection and hepatic transplantation in the treatment of hepatocellular carcinoma among cirrhotic patients. Ann Surg Oncol 2002 0.83
44 Cytological diagnosis of angiosarcoma arising in an immunosuppressed patient 6 years after multi-visceral transplantation: a case report and literature review. Diagn Cytopathol 2013 0.82
45 Internal hernia of the small bowel around infrarenal arterial conduits after liver transplantation. Clin Transplant 2002 0.82
46 An analysis of the association between serum citrulline and acute rejection among 26 recipients of intestinal transplant. Am J Transplant 2004 0.81
47 Smoking and hepatocellular carcinoma mortality. Exp Ther Med 2011 0.81
48 A cause-specific hazard rate analysis of prognostic factors among 877 adults who received primary orthotopic liver transplantation. Transplantation 2007 0.81
49 Morio Kasai: a remarkable impact beyond the Kasai procedure. J Pediatr Surg 2012 0.80
50 EspB from enterohaemorrhagic Escherichia coli is a natively partially folded protein. FEBS J 2005 0.80
51 Successful treatment of posttransplant lymphoproliferative disease with prolonged rituximab treatment in intestinal transplant recipients. Transplantation 2002 0.80
52 Role of innate and acquired immune mechanisms in clinical intestinal transplant rejection. Transplantation 2015 0.79
53 Recurrence After Liver Transplantation for Hepatocellular Carcinoma: A New MORAL to the Story. Ann Surg 2017 0.79
54 Noncomposite simultaneous liver and intestinal transplantation. Transplantation 2004 0.79
55 Host-derived enterocytes in intestinal grafts. Transplantation 2002 0.78
56 Current status of small bowel transplantation in children: update 2003. Pediatr Clin North Am 2003 0.78
57 Competing risks analysis of predictors of delisting owing to tumor progression in liver transplant candidates with hepatocellular carcinoma. Am J Transplant 2004 0.78
58 Intestinal transplantation for short bowel syndrome secondary to gastroschisis. J Pediatr Surg 2006 0.78
59 Use of the abdominal rectus fascia as a nonvascularized allograft for abdominal wall closure after liver, intestinal, and multivisceral transplantation. Transplantation 2009 0.78
60 Intestinal and multivisceral autotransplantation for tumors of the root of the mesentery: Long-term follow-up. Surgery 2012 0.78
61 Molecular expression of acute phase mediators is attenuated by machine preservation in human liver transplantation: preliminary analysis of effluent, serum, and liver biopsies. Surgery 2011 0.77
62 The importance of analyzing graft and patient survival by cause of failure: an example using pediatric small intestine transplant data. Transplantation 2006 0.77
63 Simultaneous antibody-mediated rejection of multiple allografts in modified multivisceral transplantation. Clin Transpl 2006 0.77
64 Living-donor liver transplantation: current perspective. Semin Liver Dis 2013 0.77
65 Complex hepatectomy under total vascular exclusion of the liver: impact of ischemic preconditioning on clinical outcomes. World J Surg 2013 0.76
66 Organ-specific differences in acute rejection intensity in a multivisceral transplant. Transplantation 2006 0.76
67 Morphine three-dimensional T1 gadoxetate MR cholangiography of potential living related liver donors. J Magn Reson Imaging 2013 0.76
68 The use of bi-planar tissue expanders to augment abdominal domain in a pediatric intestinal transplant recipient. Pediatr Transplant 2014 0.75
69 Living donor intestinal transplantation--should it be used more frequently? Pediatr Transplant 2006 0.75
70 Blood citrulline level is an exclusionary marker for significant acute rejection after intestinal transplantation. Transplantation 2007 0.75
71 Necrotizing fasciitis following liver and small intestine transplantation. Pediatr Transplant 2002 0.75
72 Gastrointestinal tract ulcers in pediatric intestinal transplantation patients: etiology and management. Pediatr Transplant 2006 0.75
73 Functional distal splenorenal shunt and splenic artery ligation as portal flow modulation in left lobe living donor transplantation. Liver Transpl 2014 0.75
74 Contemporaneous chronic rejection of multiple allografts with principal pancreatic involvement in modified multivisceral transplantation. Pediatr Transplant 2007 0.75
75 Use of a bioengineered skin equivalent for the management of difficult skin defects after pediatric multivisceral transplantation. J Am Acad Dermatol 2005 0.75
76 Leaning to the Left: Increasing the Donor Pool by Using the Left Lobe, Outcomes of the Largest Single-center North American Experience of Left Lobe Adult-to-adult Living Donor Liver Transplantation. Ann Surg 2016 0.75
77 Long-Term Persistence of Innate Lymphoid Cells in the Gut After Intestinal Transplantation. Transplantation 2016 0.75
78 Use of a living dermal equivalent for a refractory abdominal defect after pediatric multivisceral transplantation. Dermatol Surg 2004 0.75
79 Open lung biopsy in pediatric patients with respiratory failure after abdominal transplantation. Pediatr Transplant 2005 0.75
80 Acute cellular rejection grading scheme for human gastric allografts. Hum Pathol 2004 0.75
81 Utilization of dried blood spot citrulline level as a noninvasive method for monitoring graft function following intestinal transplantation. Transplantation 2005 0.75
82 Marked hyperbilirubinemia caused by acute cellular rejection combined with preservation injury in an infant undergoing living-related liver transplantation. Pediatr Transplant 2002 0.75
83 Analysis of acute and chronic rejection in multiple organ allografts from retransplantation and autopsy cases of multivisceral transplantation. Transplantation 2008 0.75
84 Expanding the Margins: High Volume Utilization of Marginal Liver Grafts Among >2000 Liver Transplants at a Single Institution. Ann Surg 2017 0.75
85 [Critical value of citrulline for complications of intestinal transplant graft]. Rev Assoc Med Bras 2008 0.75
86 Transplantation of en bloc pediatric kidneys with a partial bladder segment in an adult recipient. Transpl Int 2009 0.75